B of A Securities Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Neutral Recommendation

Fintel reports that on November 17, 2023, B of A Securities initiated coverage of Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Neutral recommendation.

admin